Announcements Trials
Browse Landscape

Phase

Phase 2 37Phase 1 29Phase 1/2 12Phase NA 11Phase 3 4Phase EARLY_PHASE1 3Phase 2/3 1

Status

Completed 4Unknown 2

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 3Thoracic 1

Conditions

Breast Neoplasms 3Lung Neoplasms 1Inflammatory Breast Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 299Cisplatin 298Paclitaxel 257Radiotherapy 255Fluorouracil 234Carboplatin 234Docetaxel 230Doxorubicin 216Dexamethasone 166Gemcitabine 156Vincristine 147Etoposide 136Leucovorin 133Capecitabine 129Bevacizumab 129Prednisone 125Rituximab 118Methotrexate 118Cytarabine 110Filgrastim 99Trastuzumab 97Oxaliplatin 96pembrolizumab 83Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Daunorubicin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Completed × Immunohistochemistry × Clear all
NCT01668914 2018-04-05

IMSLNB-CANP

Shandong Cancer Hospital and Institute

Phase 3 Completed
126 enrolled
Breast

Breast Neoplasms

NCT00003901 2017-02-16

Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery

Alliance for Clinical Trials in Oncology

Phase 3 Completed
1,310 enrolled 15 charts
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00003854 2016-07-13

Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
4,590 enrolled
Breast

Breast Neoplasms

NCT00017095 2013-10-24

Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
1,856 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡